The documented research protocol is 330 mcg of total blend once daily drawn to about 10 units on a U-100 syringe from a 10 mg vial reconstituted with 3 mL of bacteriostatic water
Whether or not polymorphisms in SLC22A4 adversely affect an individuals ergothioneine status and/or are linked to disease risk is also unknown
Under professional supervision, IV Glutathione infusions cause noticeable changes in the color and radiance of the skin within a period of time
Finally, the most recent therapy evidence as follow up of the above mentioned recovered endothelium function [47,56], consistently noted in major vessel occlusion studies [52,53,54,57,58,59,60,96], peripherally [52,54,57,58,59,60] or centrally [53], and peripherally and centrally [96], shows that BPC 157 therapy may activate collateral vascular pathways, which are reliant to injury occlusion